Quince Therapeutics, Inc.
QNCX
Revenue
0.00
0.000.00%
-Assets
114.48M
▼-12.04M▼-9.52%
3 Months ChangeLiabilities
84.33M
▲2.75M▲3.36%
3 Months ChangeFree Cash Flow
-8.39M
▼-4.69M▼-126.50%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-13
Form 10-Q
ID: 0001662774-24-000005
2024-08-13
Form 8-K
ID: 0001662774-24-000004
2024-06-21
Form 8-K
ID: 0001193125-24-165631
2024-06-06
Form 8-K
ID: 0001193125-24-156202
2024-05-13
Form 10-Q
ID: 0000950170-24-058201
2024-02-15
Form 8-K
ID: 0001193125-24-037521
2024-01-29
Form 8-K
ID: 0001193125-24-018071
2024-01-03
Form 8-K
ID: 0001193125-24-001482
2023-12-22
Form 8-K
ID: 0001193125-23-302116
2023-12-08
Form 8-K
ID: 0001193125-23-291671